|Table of Contents|

Efficacy and safety of open anatomic resection via the main hepatic vein approach in primary liver cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 14
Page:
2666-2672
Research Field:
Publishing date:

Info

Title:
Efficacy and safety of open anatomic resection via the main hepatic vein approach in primary liver cancer
Author(s):
GONG JieGAO FengweiLEI ZehuaJIANG KangyiXIE QingyunZHAO Xin
Department of Hepatopancreatobiliary Surgery,Leshan People's Hospital,Leshan Treatment Center of Hepatopancreatobiliary System Diseases,Sichuan Leshan 614000,China.
Keywords:
main hepatic vein approachanatomical resectionopen surgeryprimary liver cancerliver functionimmune functioninflammatory response
PACS:
R735.7
DOI:
10.3969/j.issn.1672-4992.2023.14.017
Abstract:
Objective:To explore the efficacy of open AR via the main hepatic vein approach in the treatment of primary liver cancer and its influence on perioperative indicators and postoperative complications of patients.Methods:The clinical data of 158 patients with primary liver cancer who were admitted to our hospital and underwent open anatomical resection were retrospectively analyzed between January 2016 and October 2022.Using propensity matching to match the baseline data in a 1∶1 ratio,52 pairs of samples with no statistically significant differences in baseline data were obtained.Patients who underwent open AR via the main hepatic vein approach were enrolled as study group,and patients who performed open AR via routine approach were included in routine group.The perioperative status,levels of alanine aminotransferase (ALT),aspartate aminotransferase (AST),total bilirubin (TBIL),albumin (ALB),immunoglobulin (Ig) A,IgG,IgM,CD4+T cells,CD8+T cells,interleukin-6 (IL-6),IL-10 and tumor necrosis factor-α (TNF-α) before surgery and at 7 d after surgery and postoperative related complications were compared between the two groups.Results:The intraoperative blood loss in the study group were lower than in the routine group with statistically significant differences (P<0.05).There were no statistical differences between the two groups in the operative time,percentage of patients with intraoperative blood transfusion,hepatic portal block time and hospital stay between the two groups (P>0.05).At 7 d after surgery,serum ALT,AST and TBIL levels were significantly increased (P<0.05) while serum ALB level was significantly decreased (P<0.05),and the levels of serum ALT,AST and TBIL were lower in study group than those in routine group while the level of ALB was higher than that in routine group (P<0.05).The levels of peripheral blood IgA,IgG,IgM and CD8+T cells in both groups at 7 d after surgery were significantly lower than those before surgery (P<0.05) while the level of CD4+T cells was significantly higher than that before surgery (P<0.05),and the levels of peripheral blood IgG and CD8+T cells in study group were higher than those in routine group while the level of CD4+T cells was lower than that in routine group (P<0.05).Serum levels of IL-6,IL-10 and TNF-α were significantly higher in both groups at 7 d after surgery than before surgery (P<0.05),and the levels of serum IL-6,IL-10 and TNF-α in study group were lower compared with those in routine group (P<0.05).There were no statistical differences in the incidence rates of postoperative complications between both groups (P>0.05).Conclusion:Open AR via the main hepatic vein approach is safe and feasible in the treatment of primary liver cancer,and it can reduce the intraoperative blood loss and alleviate the liver function,immune function damage and inflammatory response.In addition,it has a positive effect on promoting the rehabilitation of patients.

References:

[1]QIU H,CAO S,XU R.Cancer incidence,mortality,and burden in China:a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020[J].Cancer Commun (Lond),2021,41(10):1037-1048.
[2]LIU H,HU FJ,LI H,et al.Anatomical vs nonanatomical liver resection for solitary hepatocellular carcinoma:A systematic review and meta-analysis[J].World J Gastrointest Oncol,2021,13(11):1833-1846.
[3]高峰畏,龚杰,雷泽华,等.经肝静脉主干入路行解剖性肝脏切除术临床效果及安全性[J].山东医药,2018,58(8):78-80. GAO FW,GONG J,LEI ZH,et al.Clinical effectiveness and safety of anatomical hepatectomy via hepatic vein trunk access[J].Shandong Medical Journal,2018,58(8):78-80.
[4]尤楠,李靖,吴柯,等.腹腔镜下以肝中静脉为引导的肝实质优先入路解剖性肝脏S8段切除的临床应用价值[J].中国普外基础与临床杂志,2021,28(2):146-150. YOU N,LI J,WU K,et al.Clinical application value of laparoscopic anatomical resection of liver segment 8 via a hepatic parenchymal transection-first approach guided by the middle hepatic vein[J].Chinese Journal of Bases and Clinics in General Surgery,2021,28(2):146-150.
[5]吴泓,谢坤林,黄纪伟,等.经肝圆韧带裂入路肝切除术的临床疗效[J].中华消化外科杂志,2016,15(01):53-57. WU H,XIE KL,HUANG JW,et al.Clinical effect of fissure for ligamentum teres hepatic approach in hepatectomy[J].Chinese Journal of Digestive Surgery,2016,15(01):53-57.
[6]龚杰,雷泽华,高峰畏,等.沿肝静脉主干入路行腹腔镜解剖性肝切除术治疗原发性肝癌的临床效果观察[J].实用医院临床杂志,2020,17(5):73-76. GONG J,LEI ZH,GAO FW,et al.Clinical effect observation of laparoscopic anatomical hepatectomy via main hepatic vein approach[J].Practical Journal of Clinical Medicine,2020,17(5):73-76.
[7]廖科曦,曹利,黄登,等.腹腔镜下肝静脉导向解剖性肝切除术治疗肝细胞癌的临床研究[J].中华肝胆外科杂志,2020,26(5):339-344. LIAO KX,CAO L,HUANG D,et al.A clinical study on laparoscopic hepatic vein-guided anatomical hepatectomy for hepatocellular carcinoma[J].Chinese Journal of Hepatobiliary Surgery,2020,26(5):339-344.
[8]中华人民共和国国家卫生健康委员会医政医管局.原发性肝癌诊疗规范(2019年版)[J].中华消化外科杂志,2020,19(1):1-20. Medical Administration of the National Health and Health Commission of the People's Republic of China.Standardization for diagnosis and treatment of hepatocellular carcinoma (2019 edition) [J].Chinese Journal of Digestive Surgery,2020,19(1):1-20.
[9]OKAMURA Y,SUGIURA T,ITO T,et al.Anatomical resection is useful for the treatment of primary solitary hepatocellular carcinoma with predicted microscopic vessel invasion and/or intrahepatic metastasis[J].Surg Today,2021,51(9):1429-1439.
[10]HIDAKA M,EGUCHI S,OKUDA K,et al.Impact of anatomical resection for hepatocellular carcinoma with microportal invasion (vp1):A multi-institutional study by the Kyushu study group of liver surgery[J].Ann Surg,2020,271(2):339-346.
[11]洪海杰,蔡欣然,陈敏敏,等.腹腔镜解剖性与非解剖性肝切除术治疗原发性肝癌的近、远期疗效分析[J].福建医科大学学报,2021,55(2):116-120. HONG HJ,CAI XR,CHEN MM,et al.Analysis of the treatment efficacy of laparoscopic anatomic and non-anatomic hepatectomy for primary liver cancer[J].Journal of Fujian Medical University,2021,55(2):116-120.
[12]WANG S,YUE Y,ZHANG W,et al.Dorsal approach with Glissonian approach for laparoscopic right anatomic liver resections[J].BMC Gastroenterol,2021,21(1):138-153.
[13]BERARDI G,IGARASHI K,LI CJ,et al.Parenchymal sparing anatomical liver resections with full laparoscopic approach:description of technique and short-term results[J].Ann Surg,2021,273(4):785-791.
[14]金浩,刘会春,满忠然,等.完全腹腔镜下肝外Glisson鞘内解剖性肝切除术[J].中国微创外科杂志,2020,20(4):304-308. JIN H,LIU HC,MAN ZR,et al.Application of complete laparoscopic extrahepatic Glisson intrathecal anatomic hepatectomy[J].Chinese Journal of Minimally Invasive Surgery,2020,20(4):304-308.
[15]TAKASAKI K.Glissonean pedicle transection method for hepatic resection:a new concept of liver segmentation[J].J Hepatobiliary Pancreat Surg,1998,5(3):286-291.
[16]夏果毅,刘苏来,宋颖辉,等.Glisson蒂鞘外与鞘内法在腹腔镜解剖性右肝后叶切除的对比研究[J].中国普通外科杂志,2021,30(7):798-804. XIA GY,LIU SL,SONG YH,et al.A comparative study of extra-versus intra-Glissonian approach in laparoscopic anatomical right posterior lobe resection[J].Chinese Journal of General Surgery,2021,30(7):798-804.
[17]BERARDI G,WAKABAYASHI G,IGARASHI K,et al.Full laparoscopic anatomical segment 8 resection for hepatocellular carcinoma using the glissonian approach with indocyanine green dye fluorescence[J].Ann Surg Oncol,2019,26(8):2577-2578.
[18]李云峰,尹新民.腹腔镜解剖性肝Ⅶ段切除术的难点与应对策略[J].中华消化外科杂志,2021,20(2):178-183. LI YF,YIN XM.Challenges and tactics of laparoscopic anatomical hepatectomy of segment 7[J].Chinese Journal of Digestive Surgery,2021,20(2):178-183.
[19]MACHADO MAC,ARDENGH AO,LOBO FILHO MM,et al.Robotic anatomical resection of liver segment 4 with glissonian approach and selective hepatic artery clamping[J].Arq Gastroenterol,2021,58(1):127-128.
[20]CHIBA N,ABE Y,NAKAGAWA M,et al.The "tenting sign of the hepatic vein" is important for laparoscopic anatomical hepatectomy along the major hepatic vein[J].J Gastrointest Surg,2020,24(6):1448-1451.
[21]CIRIA R,BERARDI G,NISHINO H,et al.A snapshot of the 2020 conception of anatomic liver resections and their applicability on minimally invasive liver surgery.A preparatory survey for the expert consensus meeting on precision anatomy for minimally invasive HBP surgery[J].J Hepatobiliary Pancreat Sci,2022,29(1):41-50.
[22]高峰畏,吴泓,雷泽华,等.沿肝静脉入路的解剖性肝切除技术特点及临床效果[J].西部医学,2017,29(07):939-943. GAO FW,WU H,LEI ZH,et al.Hepatic vein approach in anatomical hepatectomy[J].Medical Journal of West China,2017,29(07):939-943.
[23]齐硕,陈国栋.循肝中静脉腹腔镜解剖性半肝切除术的经验体会[J].中国现代手术学杂志,2021,25(5):334-340. QI S,CHEN GD.Experience of Laparoscopic anatomical hemihepatectomy following the middle hepatic vein[J].Chinese Journal of Modern Operative Surgery,2021,25(5):334-340.
[24]肖亮,方统迪,龙果,等.优先解剖肝实质法在腹腔镜下鞘外肝蒂血流阻断中的应用:附解剖性肝中叶切除1例[J].中国普通外科杂志,2020,29(7):798-805. XIAO L,FANG TD,LONG G,et al.Application of liver parenchymal dissection-first method in laparoscopic extra-Glissonian inflow occlusion:a case of anatomical mesohepatectomy[J].Chinese Journal of General Surgery,2020,29(7):798-805.
[25]吴宝强,吴勇,何振飞,等.腹腔镜半肝切除术中肝中静脉显露的临床研究[J].中华肝胆外科杂志,2020,26(12):886-890. WU BQ,WU Y,HE ZF,et al.A retrospective study on exposure versus non-exposure of middle hepatic vein in laparoscopic hemihepatectomy[J].Chinese Journal of Hepatobiliary Surgery,2020,26(12):886-890.

Memo

Memo:
四川省医学科研课题计划(编号:Q18027)
Last Update: 1900-01-01